Chronic Kidney Disease: Common, Harmful and Treatable – World Kidney Day 2007

作者: Andrew S. Levey , Sharon P. Andreoli , Thomas DuBose , Robert Provenzano , Allan J. Collins

DOI: 10.1159/000099801

关键词: DialysisNephrologyMedicineHealth careTransplantationNational Health and Nutrition Examination SurveyKidney diseaseIntensive care medicinePublic healthDiseaseInternal medicine

摘要: T hursday, March 8, 2007, is World Kidney Day! Day was proposed by the International Society of Nephrology and Federation Foundations in 2006 to broadcast a message about kidney diseases public, government health officials, general physicians, allied professionals, individuals, families. It launched on 9, 2006, will be fully inaugurated this year (http://www.worldkidneyday.org/). The that disease common, harmful, treatable. In article, we focus chronic (CKD) as global public problem urgent need for all countries have policy CKD. Until recently, decision makers biomedical science had viewed CKD uncommon, without consequences, untreatable until stage failure. care patients with been marginalized, relegated subspecialty nephrology, payment primarily directed at dialysis transplantation, which are too costly vast majority people who live outside developed world. At same time, costs other mounting. countries, hypertension, diabetes, cardiovascular (CVD) consume large fraction resources care. epidemic obesity magnify these costs, young well elderly. developing burden noncommunicable rising even though communicable not yet under control. We now recognize especially common multiplies risk adverse outcomes costs. mandate clear. No country can afford overlook CKD; prevention, early detection, intervention only cost-effective strategies. following paragraphs, outline rationale key elements integrating programs diseases. Rationale Figure 1 shows conceptual model basis approach, emphasizing stages CKD, antecedents, outcomes, factors development progression defined either damage, estimated from markers such albuminuria, or GFR 60 ml/min per 1.73 m 3 mo more (1–3). Albuminuria usually spot urine protein-to-creatinine ratio 30 mg/g, serum creatinine, age, gender, race. United States, recent data National Health Nutrition Examination Survey (NHANES) estimate prevalence 9.6% noninstitutionalized adults, corresponding approximately 19 million (Table 1) (4,5). elderly, racial ethnic minorities, those lower socioeconomic status disproportionately affected. Prevalence estimates difficult interpret because differences creatinine levels result variability among studies assays, muscle mass, diet. Nonetheless, both nations, consistent picture emerging increased CVD established CVD. most important include complications decreased failure but also Many show albuminuria each consistently graded manner increase (6). Indeed, showed 100 times likely die, principally CVD, than develop (7). There convincing efficacy treatment prevent GFR, slow disease, reduce risk. Testing feasible clinical practice, methods applied large-scale screening Therefore, tools improve already available. time establish policies translate advances health.

参考文章(20)
Steven G. Coca, Harlan M. Krumholz, Amit X. Garg, Chirag R. Parikh, Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease JAMA. ,vol. 296, pp. 1377- 1384 ,(2006) , 10.1001/JAMA.296.11.1377
Johannes F.E. Mann, Hertzel C. Gerstein, Janice Pogue, Jackie Bosch, Salim Yusuf, , Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial Annals of Internal Medicine. ,vol. 134, pp. 629- 636 ,(2001) , 10.7326/0003-4819-134-8-200104170-00007
Andrew S Levey, Kai-Uwe Eckardt, Yusuke Tsukamoto, Adeera Levin, Josef Coresh, Jerome Rossert, Dick DE Zeeuw, Thomas H Hostetter, Norbert Lameire, Garabed Eknoyan, None, Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney International. ,vol. 67, pp. 2089- 2100 ,(2005) , 10.1111/J.1523-1755.2005.00365.X
Scott D. Solomon, Madeline M. Rice, Kathleen A. Jablonski, Powell Jose, Michael Domanski, Marc Sabatine, Bernard J. Gersh, Jean Rouleau, Marc A. Pfeffer, Eugene Braunwald, Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation. ,vol. 114, pp. 26- 31 ,(2006) , 10.1161/CIRCULATIONAHA.105.592733
S. Y.S. Kimm, E. Obarzanek, Childhood obesity: a new pandemic of the new millennium. Pediatrics. ,vol. 110, pp. 1003- 1007 ,(2002) , 10.1542/PEDS.110.5.1003
Luis Carreras, Rafael Poveda, Jordi Bas, Mariona Mestre, Inés Rama, Marta Carrera, Goodpasture syndrome during the course of a Schönlein-Henoch purpura American Journal of Kidney Diseases. ,vol. 39, pp. E21- ,(2002) , 10.1053/AJKD.2002.32799
Marcello Tonelli, Lemuel Moy, Frank M. Sacks, Bryce Kiberd, Gary Curhan, , Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency Annals of Internal Medicine. ,vol. 138, pp. 98- 104 ,(2003) , 10.7326/0003-4819-138-2-200301210-00010
Douglas S. Keith, Gregory A. Nichols, Christina M. Gullion, Jonathan Betz Brown, David H. Smith, Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization Archives of Internal Medicine. ,vol. 164, pp. 659- 663 ,(2004) , 10.1001/ARCHINTE.164.6.659
Lesley A Stevens, Josef Coresh, Tom Greene, Andrew S Levey, None, Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate New England Journal of Medicine. ,vol. 354, pp. 2473- 2483 ,(2006) , 10.1056/NEJMRA054415